Bruno Medeiros
Publication Details
-
Impact of residual normal metaphases in core binding factor acute myeloid leukemia.
Cancer. 2012; (9): 2420-3
Karyotype allows for stratification of outcomes in acute myeloid leukemia (AML) patients. Previous data suggested that the presence of residual normal cells improved the prognosis in patients with monosomy 7. The Southwest Oncology Group (SWOG) reported the impact of residual normal metaphases in AML patients with monosomal karyotype (MK) and found a similar relationship. We determined the influence of residual normal metaphases in patients with core binding factor (CBF) AML.
Help
Trial Administration